EXTRA OSSEOUS PRIMARY EWING’S SARCOMA
Abstract
The case of 20 years old boy with an extra osseous Ewing’s sarcoma is described. He was initiallydiagnosed as a case of infiltrative malignant tumour of left suprarenal gland on the basis of preoperativeworkup but postoperative biopsy of surgically excised specimen confirmed Extra-osseous Ewing’sSarcoma (EES) suprarenal gland with no evidence of malignancy on skeletal scintiscan, bone marrowaspirate and histopathology. Suprarenal location of primary EES is unknown and probably has not beenreported in literature. We report a unique case of EES.Keywords: Ewing’s sarcoma, extra osseous, suprarenal gland, managementReferences
Angervall L, Enzinger FM. Extra skeletal neoplasm resembling
Ewing’s Sarcoma Cancer 1975;36:240–51.
Rud NP, Reiman HM, Pritchard DJ, Frassica FJ, Smithson WA.
Extraosseous Ewing’s Sarcoma –A study of 42 cases. Cancer
;64:1548–53.
Ladany M, Heinemann FS, Huvos AG, Hanumantha Rao P,
Chen Q, Jhanwar SC. Neural differentiation in small round cell
tumor of bone and soft tissue with the translocation t(11;22)
(q24;q12): An immunohistochemical study of 11 cases. Human
Pathol 1990;21:1245–51.
Miller ME, Emerson L, Clayton F, Bentz BG, Data RE, Salzman
KL, et al. Extraosseous Ewing’s sarcoma. J Clin Oncol
;25:4845–8.
Ambros IM, Ambros PF, Strehl S, Kovar H, Gadner H, SalzerKuntschik M. MIC2 is a specific marker for Ewing’s sarcoma
and peripheral primitive neuroectodermal tumors. Evidence for a
common histogenesis of Ewing’s sarcoma and peripheral
primitive neuroectodermal tumors from MIC2 expression and
specific chromosome aberration. Cancer 1991;67:1886–93.
Brehaut LE, Anderson LH, Taylor DA. Extraskeletal Ewing’s
Sarcoma: Diagnosis of a case by fine needle aspiration cytology.
Acta Cytol 1986;30:683–7.
Kara G: Spinal Cord Ewing’s sarcoma Metastasis: presentation
of one case. Ann Nucl Med 2004;18:623–6.
Bacci G, Balladelli A, Forni C, Ferrari S, Longhi A, Bacchini P,
et al. Adjuvant and neoadjuvant chemotherapy for Ewing
sarcoma family tumors in patients aged between 40 and 60:
report of 35 cases and comparison of results with 586 younger
patients treated with the same protocols in the same years. Cancer
;109:780–6.
Kolb EA, Kushner BH, Gorlick R, Laverdiere C, Healey JH,
LaQuaglia MP, et al. Long-term event-free survival after
intensive chemotherapy for Ewing’s family of tumors in children
and young adults. J Clin Oncol 2003;21:3423–30.
Moodley M, Jordaan A: Ewings sarcoma of the vulva ‒a case
report. Int J Gynecol Cancer 2005;15:1177–8.
Published
Issue
Section
License
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
